Garuda - Garba Rujukan Digital

Article Per Year (5 Year)

All

Medical Journal of Indonesia

MJI
Website

Published by Universitas Indonesia

ISSN : 08531773 EISSN : 22528083 DOI : 10.13181

Core Subject : Health,

Medicine & Pharmacology

This quarterly medical journal is an official scientific journal of the Faculty of Medicine Universitas Indonesia in collaboration with German-Indonesian Medical Association (DIGM) Indexed in: IMSEAR; CAB Abstracts; Global Health; HINARI; DOAJ; DRJI; Google Scholar; JournalTOCs; Ulrichsweb Global Serial Directory; WorldCat; New Jour; Electronic Journals Library; ISJD Accredited (2013-2018) by DIKTI Kemendikbud Republik Indonesia (No:58/DIKTI/Kep/2013)

Arjuna Subject : -

Articles 9 Documents

Search results for , issue " Vol 17, No 4 (2008): October-December" : 9 Documents clear

The possible role of nutritional intervention to prevent diabetic retinopathy Pawitan, Jeanne A.
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

[No Abstract Available]

Fat free mass index as parameter for nutritional status in non-dialysis chronic kidney disease patients stage 3, 4 and 5 Kumala, Meilani; Lukito, Widjaja; Sastroamidjojo, Soemilah; Prodjosudjadi, Wiguno
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

The aim of this study is to obtain body composition parameters for early detection of PEM in non dialysis CKD (ND-CKD) patients. The study was carried out using the cross sectional design. The subjects of the study consist of 45 ND-CKD patients and 45 healthy subjects matched for age, gender, height and body mass index (BMI). The nutritional status of patients and healthy subjects were classified based on BMI (WHO, 1995) into low, normal and high nutritional status groups. Fat free mass (FFM), FFM-index (FFM-I) and percentage of fat mass (FM percentage) in patients measured by anthropometric technique showed no significant difference with healthy subjects. Using the BIAÂ method, FFM and FFM-I were significantly lower in the ND-CKD patients compared to the healthy subjects (p < 0,05). Significant difference in FFM, FFM-I, FM and FM percentage was observed between the patients with different nutritional status. (p < 0,001). Trend analysis statistical test showed that there is linear correlation of FFM, FFM-I and FM with nutritional status classification. FFM, FFM-I, FM and FM percentage in ND-CKD patients were not significantly different between the three stages of CKD. There was an acceptable degree of agreement between BMI with FFM-I for nutritional assessment in ND-CKD patients. The Receiver Operating Curve test showed the cut off points of FFM-I 14.23 kg/m2 to differentiate undernutrition and normal nutritional status in ND-CKD patients. This study showed FFM-I has good correlation with BMI and can be used to differentiate degrees of nutritional status in stage 3, 4 and 5 ND-CKDÂ patients. FFM-I considered predictor parameters for nutritional status screening in ND-CKD patients. (Med J Indones 2008; 17: 240-7)Keywords: Non dialysis chronic kidney disease, protein energyÂ malnutrition, body composition, fat free mass, fat free mass index

Relationship between plasma lipid profile and the severity of diabetic retinopathy in type 2 diabetes patients Rianita, Rianita; Bardosono, Saptawati; Victor, Andi A.
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

This study aimed to determine the relationship between plasma lipid profile and the severity of diabetic retinopathy in type 2 diabetes patients. A cross sectional study was done inÂ Ophthalmologic Clinic, Cipto Mangunkusumo General Hospital, Jakarta for 52 diabetic retinopathy (DR) patients. Data collected were demographic, life style, duration of diabetes, physical and antropometric examinations, fat, fatty acid and cholesterol intake, fasting plasma glucose, A1C, total-, LDL-,HDL-cholesterol and triglyceride level, and fundus examination. Statistical analysis was done using chi-square test to see the associations between plasma lipid profile and DR in type 2 diabetes patients. Subjects comprised of 20 males and 32 females diabetes patients with mean age of 53.8 Â± 5.2 years. As much as 53.8% had been diagnosed as DM for >10 years. The mean value of BMI was 24.1 Â± 3.3 kg/m2 and 38.5% were classified as obese I and II. The mean value of fasting plasma glucose was 157.5 Â± 71.8 mg/dL, and A1C was 9.1 Â± 2.4 %. For lipid profile, 40.4% had high total cholesterol level (>240 mg/dL), 34.6% had high and very high LDL-cholesterol level (â¥160 mg/dL), and 65.4% had normal HDL-cholesterol (40-60 mg/dL) and triglyceride level (<150 mg/dL). For the severity of retinopathy, 61.6% had severe non-proliferative diabetic retinopahy (NPDR) and proliferative diabetic retinopahy (PDR). In conclusion, there were no significant associations between plasma lipid profile and the severity of diabetic retinopathy. (Med J Indones 2008; 17: 221-5)Keywords: Fat intake, lipid profile, diabetic retinopathy

Risk Factors of anemia in head and neck cancer patients undergoing chemotherapy with high-dose cisplatin Kurnianda, Johan; Wiyadi, Nugroho; Wulaningsih, Wahyu
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

Cisplatin is well-known for its effectiveness against cancer, as well as its toxicity to human tissues. Of several documented side effects, anemia was reported to have significant association with decreased quality of life. This study was conducted to investigate development of cisplatin-induced anemia, and to identify independent factors contributing to anemia. Clinical data from head and neck cancer patients treated with high-dose cisplatin between December 2002 and December 2005 were obtained in this study. Incidence and risk factors of anemia were assessed in a model including age, sex, baseline hemoglobin level, baseline creatinine clearance, and occurrence of distant metastases. Multivariate logistic regression was used to define independent predictors of anemia. Among 86 eligible patients, 26 (30.2%) developed anemia, defined as Hb level lower than 11 g/dL. Age > 55 years old (RR = 2.2, 95% CI, 1.2-4.0), female sex (RR = 2.0, 95% CI, 1.2-3.8), baseline Hb â¤ 13 g/dL (RR = 4.2, 95% CI, 1.9-9.4) and baseline CrCl < 50 mL/min (RR = 2.9, 95% CI, 1.7-5.1) were significantly correlated with incidence of anemia (P < 0.05). In multivariate analysis, baseline Hb and baseline CrCl were identified as independent risk factors for anemia. However, considerable confounding was observed in baseline CrCl after stratified by age (aRR = 2.2, 95% CI, 1.1-4.7). Thus, baseline Hb level was the strongest predictor of anemia. The findings suggested that baseline Hb and CrCl were useful to recognize cisplatin-treated patients at risk for anemia who might benefits from preventive measures. (Med J Indones 2008; 17: 248-54)Keywords: anemia, cisplatin, chemotherapy, hemoglobin, creatinine clearance

Cushings syndrome induced by misuse of topical corticosteroids in a child with psoriasis vulgaris Rahmayunita, Githa; Pulungan, Aman B.; Wiryadi, Benny E.; Wisesa, Tina W.; Sugito, Titi L.; Boediardja, Siti A.
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

Prolonged exc)genous corticosteroid aclministration may cause Cushingi syndrome. Howeve7 the development of Cushings syndrome from topical corlico,sleroid therapy is rare. AÂ 7%-year- old boy has sufferedfrom psoriasis vulgaris since the age of nvo. He was treated by a dermatologist with a mixlure of 3% salicylic acid, 50% liquor carbonis delergens, 10 grams of 0.1% mometasonefuroate ointment, ancl 5 grams combination cream consisting of 0.1% gentamycin sulphate and 0.0250 Ãfiuocinolone acetonide. The parents continued the treatment without the doctorb supervision. They applied it lo all over the patients body three times dailyfor 3% years. The patient showed milcl hypertension, moonface, btffilo hump, obesity, multiple striae, and suppression of hypothalamus-pituitary-adrenal axis. The bone minerttl density and bone age examinations revealed normal results. Children are more prone to develop systemic side fficts of topical medicalion beccntse o/their higher ratio of btal body surface area to body weight. Corticosteroid must be used with great care, especially in children. It is very important to inform the parents abott polential side effects of corticosteroid. (Med J Indones 2008; 17: 281-6)Keywords: Cushings syndrome - topical corticosleroids, sicle fficts

The safety and efficacy of feracrylum as compared to silver sulfadiazine in the management of deep partial thickness burn: A clinical study report Moenadjat, Yefta; Setiabudy, Rianto; Astrawinata, Dalima A.W.; Gumay, Saukani
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

Instead of haemostatic effect, feracrylum provides antibacterial activity; wound improvement has been clinically proven. Feracrylum is a water soluble mixture of incomplete ferrous salt of polyacrylic acid containing 0.05 to 0.5% of iron in physiologic solution (0.85% solution of sodium chloride). A clinical study on safety and efficacy of feracrylum compared to silver sulfadiazine (SSD) was conducted in burn management, since with the widely use of SSD, the sulfadiazineâs disadvantages lead to wound healing impairment. In this open, randomized, controlled study, feracrylum and SSD were topically applied, each on different side of the burnt areas in parts of body for a treatment period of eleven days. Of eight enrolled patients, seven patients completed the study; one patient withdrew due to acute burn complication. On day 7th and 11th, the re-epithelialization in group receiving feracrylum increased as the raw surface area reduced. Mean percentages of epithelialization on both evaluation days in Feracrylum group were 70.53Â±24.298 and 81.71Â±28.922, respectively, which were higher than SSD group (66.15Â±25.080 and 64.64Â±74.684 respectively). Feracrylum was found to be safe and well tolerated. This study showed a clinical difference although it was not significant statistically. (Med J Indones 2008; 17: 259-71)Keywords: Feracrylum, silver sulfadiazine, wound management

Cleft lip and palate review: Epidemiology, risk factors, quality of life, and importance of classifications Supit, Laureen; Prasetyono, Theddeus O.H.
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

Cleft lip with or without cleft palate is the most occurring craniofacial anomaly in human, resulting from a complex etiology involving multiple genetic and environmental factors. The defect carries lifelong morbidity and economic burden. Children with clefts will require continuous medical interventions for at least the first 18 years of life, affecting many aspects of their lives. The extent and complexity of clefts vary infinitely, later determining individual management and outcome. Identification and classification play significant roles in initial assessment of these unique cleft cases, which affect options for following correctional attempts. Some classifications even allow measurement of progress after anatomical repositioning, and success rate after surgical repairs. The challenge of developing one such widely inclusive classification is discussed. (Med J Indones 2008; 17: 226-39)Keywords: Cleft lip, cleft palate, congenital anomaly, cleftÂ classfications

Economic burden of cervical cancer in Malaysia Puteh, Sharifa E.W.; Ng, Paul; Aljunid, Syed M.
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

Cervical cancers form the second highest number of female cancers in Malaysia, imposing a substantial amount of cost burden on its management. However, an estimation of cost burden of abnormal smears, cervical pre-invasive and invasive diseases needs to be done to show how much spending has been allocated to the problem. An expert panel committee came up with the clinical pathway and management algorithm ofÂ cervical pre invasive and invasive diseases from July-December 2006 Malaysia. An activity based costing for each clinical pathway was done. Results were converted to USD. The cost of managing pre-invasive cervical cancers stage is USD 420,150 (Range: USD 197,158-879,679). Management of invasive cancer (new cases) costs USD 51,533,233.44 (Range: USD 32,405,399.69 - USD 129,014,768.40). The cost of managing existing cases is USD 17,005,966.87 (Range: USD 10,693,781.90 - USDÂ 28,901,587.12). The total cost of managing cervical cancers by health care providers in a public setting is around USD 75,888,329.45 (Range: USD 48,083,804.60 - USD 48,083,804.60). The outcome of this study has shown that preventive modalities such as screening have only contributed to 10.3 % of the total management cost of cervical cancer. The major cost contribution (67%) came from treatment of invasive cancer especially at more advanced stages of cancer, followed by treatment of existing cases (22%) and lastly on pre-invasive disease (0.6%). This study revealed that proportion of preventive modality in this country was still low, and the major cost came from actual treatment cost of cervical cancer. Therefore, heightened public cervical cancer screening in the country is needed. (Med J Indones 2008; 17: 272-80)Keywords: cervical cancers, pre invasive disease, HPV vaccination

Pre operative radiation for icteric type hepatocellular carcinoma A case report Nugroho, Adianto; Lalisang, Toar J.M.; Gondhowiarjo, Soehartati
Medical Journal of Indonesia Vol 17, No 4 (2008): October-December
Publisher : Faculty of Medicine Universitas Indonesia

Hepatocellular Carcinoma (HCC) is still a leading health problem worldwide, due to its correlation with HBV and HCV infection and its management which is strongly dependent on patientâs condition and tumor extension. Surgery, with liver resection or liver transplantation offer a good survival rate as a primary management of such cancer. But since liver resection must consider some aspect of liver function and tumor size, and liver transplantation was not a choice in Indonesia, many treatment modalities has been developed which can be used to overcome this problem, such as tumor ablation, transarterial chemo embolization (TACE), chemotherapy and radiotherapy. With the development of conformal radiotherapy, the hepatitis induced radiation therapy could be minimized. This paper present a case of conformal radiation therapy utilization in icteric type HCC in Dr. Cipto Mangunkusumo Hospital, Jakarta. Hepatic resection was planned for this patient. (Med J Indones 2008; 17: 255-8)Keywords: Hepatocellular Carcinoma, icteric type, radiation therapy, conformal radiotherapy

Page 1 of 1 | Total Record : 9

Filter by Year

2008 2008

Filter By Issues

All Issue Vol. 34 No. 3 (2025): September Vol. 34 No. 2 (2025): June Vol. 34 No. 1 (2025): March Online First Vol. 33 No. 4 (2024): December Vol. 33 No. 3 (2024): September Vol. 33 No. 2 (2024): June Vol. 33 No. 1 (2024): March Vol. 32 No. 4 (2023): December Vol. 32 No. 3 (2023): September Vol 28, No 1 (2019): March Vol 27, No 4 (2018): December Vol 27, No 3 (2018): September Vol 27, No 2 (2018): June Vol 27, No 1 (2018): March Vol 26, No 4 (2017): December Vol 26, No 3 (2017): September Vol 26, No 2 (2017): June Vol 26, No 1 (2017): March Vol 25, No 4 (2016): December Vol 25, No 3 (2016): September Vol 25, No 2 (2016): June Vol 25, No 1 (2016): March Vol 24, No 4 (2015): December Vol 24, No 3 (2015): September Vol 24, No 2 (2015): June Vol 24, No 1 (2015): March Vol 23, No 4 (2014): November Vol 23, No 3 (2014): August Vol 23, No 2 (2014): May Vol 23, No 1 (2014): February Vol 22, No 4 (2013): November Vol 22, No 3 (2013): August Vol 22, No 2 (2013): May Vol 22, No 1 (2013): February Vol 21, No 4 (2012): November Vol 21, No 3 (2012): August Vol 21, No 2 (2012): May Vol 21, No 1 (2012): February Vol 20, No 4 (2011): November Vol 20, No 3 (2011): August Vol 20, No 2 (2011): May Vol 20, No 1 (2011): February Vol 19, No 4 (2010): November Vol 19, No 3 (2010): August Vol 19, No 2 (2010): May Vol 19, No 1 (2010): February Vol 18, No 4 (2009): October-December Vol 18, No 3 (2009): July-September Vol 18, No 2 (2009): April-June Vol 18, No 1 (2009): January-March Vol 17, No 4 (2008): October-December Vol 17, No 3 (2008): July-September Vol 17, No 2 (2008): April-June Vol 17, No 1 (2008): January-March Vol 16, No 4 (2007): October-December Vol 16, No 3 (2007): July-September Vol 16, No 2 (2007): April-June Vol 16, No 1 (2007): January-March Vol 15, No 4 (2006): October-December Vol 15, No 3 (2006): July-September Vol 15, No 2 (2006): April-June Vol 15, No 1 (2006): January-March Vol 14, No 4 (2005): October-December Vol 14, No 3 (2005): July-September Vol 14, No 2 (2005): April-June Vol 14, No 1 (2005): January-March Vol 13, No 4 (2004): October-December Vol 13, No 3 (2004): July-September Vol 13, No 2 (2004): April-June Vol 13, No 1 (2004): January-March Vol 12, No 4 (2003): October-December Vol 12, No 3 (2003): July-September Vol 12, No 2 (2003): April-June Vol 12, No 1 (2003): January-March Vol 11, No 4 (2002): October-December Vol 11, No 3 (2002): July-September Vol 11, No 2 (2002): April-June Vol 11, No 1 (2002): January-March Vol 10, No 4 (2001): October-December Vol 10, No 3 (2001): July-September Vol 10, No 2 (2001): April-June Vol 10, No 1 (2001): January-March Vol 9, No 4 (2000): October-December Vol 9, No 3 (2000): July-September Vol 9, No 2 (2000): April-June (Special Issue: Skin Cancer) Vol 9, No 1 (2000): January-March Vol 8, No 4 (1999): October-December Vol 8, No 3 (1999): July-September Vol 8, No 2 (1999): April-June (Special Issue: Breast Cancer) Vol 8, No 1 (1999): January-March (Special Issue: Implant Contraceptive) Vol 7, No 4 (1998): October-December Vol 7, No 3 (1998): July-September Vol 7, No 2 (1998): April-June Vol 7 (1998): Supplement 1 Vol 7, No 1 (1998): January-March Vol 6, No 4 (1997): October-December Vol 6, No 3 (1997): July-September Vol 6, No 2 (1997): April-June Vol 6, No 1 (1997): January-March Vol 5, No 4 (1996): October-December Vol 5, No 3 (1996): July-September Vol 5, No 2 (1996): April-June Vol 5, No 1 (1996): January-March Vol 4, No 4 (1995): October-December Vol 4, No 3 (1995): July-September Vol 4, No 2 (1995): April-June Vol 4, No 1 (1995): January-March Vol 3, No 4 (1994): October-December Vol 3, No 3 (1994): July-September Vol 3, No 2 (1994): April-June Vol 3, No 1 (1994): January-March Vol 2, No 1 (1993): January-March Vol 1, No 3/4 (1992): July-December Vol 1, No 2 (1992): April-June Vol 1, No 1 (1992): January-March More Issue

Home Page

OAI Link

Editorial Team

Contact

Reviewer

Google Scholar

Contact Name
-

Contact Email
-

Phone
-

Journal Mail Official
mji@ui.ac.id

Editorial Address
Education Tower 6th floor, IMERI building, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya 6, Jakarta, 10430, Indonesia

Location
Kota depok,

Jawa barat

INDONESIA

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Home Page

OAI Link

Editorial Team

Contact

Reviewer

Google Scholar

Contact Name -

Contact Email -

Phone -

Journal Mail Official mji@ui.ac.id

Editorial Address Education Tower 6th floor, IMERI building, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya 6, Jakarta, 10430, Indonesia

Location Kota depok, Jawa barat INDONESIA

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Contact Name
-

Contact Email
-

Phone
-

Journal Mail Official
mji@ui.ac.id

Editorial Address
Education Tower 6th floor, IMERI building, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya 6, Jakarta, 10430, Indonesia

Location
Kota depok,

Jawa barat

INDONESIA